Canopy Growth (CGC) Total Liabilities (2017 - 2026)
Canopy Growth (CGC) posted Total Liabilities of $307.1 million for Q1 2026, up 19.27% sequentially from $257.5 million in Q4 2025, and little changed YoY from $306.0 million in Q1 2025.
Canopy Growth (CGC) Total Liabilities (2017 - 2026) Analysis & Trends
Canopy Growth has reported Total Liabilities for 10 years, with the latest figure at $307.1 million in Q1 2026.
- Quarterly Total Liabilities changed 0.34% year-over-year to $307.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $307.1 million (changed 0.34% YoY) and the FY2026 annual result came in at $307.1 million, changed 0.34% from the prior year.
- Total Liabilities improved to $307.1 million in Q1 2026 per CGC's latest filing, from $257.5 million in the prior quarter.
- Over five years, Total Liabilities peaked at $1.6 billion in Q1 2022 and troughed at $253.7 million in Q3 2025.
- A 5-year average of $750.7 million and a median of $605.7 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Liabilities slumped 54.94% in 2025, then grew 0.34% in 2026.
- Over 5 years, Total Liabilities stood at $1.2 billion in 2022, then sank by 47.99% to $605.7 million in 2023, then dropped by 28.35% to $434.0 million in 2024, then plunged by 40.67% to $257.5 million in 2025, then rose by 19.27% to $307.1 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $307.1 million, $257.5 million, and $253.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn | 300.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 300.22 Mn |
| Mar 31, 2026 | 307.10 Mn |
| Dec 31, 2025 | 257.47 Mn |
| Sep 30, 2025 | 253.70 Mn |
| Jun 30, 2025 | 308.66 Mn |
| Mar 31, 2025 | 306.04 Mn |
| Dec 31, 2024 | 433.96 Mn |
| Sep 30, 2024 | 563.01 Mn |
| Jun 30, 2024 | 598.88 Mn |
| Mar 31, 2024 | 667.73 Mn |
| Dec 31, 2023 | 605.71 Mn |
| Sep 30, 2023 | 700.74 Mn |
| Jun 30, 2023 | 999.82 Mn |
| Mar 31, 2023 | 1.24 Bn |
| Dec 31, 2022 | 1.16 Bn |
| Sep 30, 2022 | 1.35 Bn |
| Jun 30, 2022 | 1.44 Bn |
| Mar 31, 2022 | 1.57 Bn |
| Dec 31, 2021 | 1.66 Bn |
| Sep 30, 2021 | 1.73 Bn |